Heart Short Long Term Debt vs Net Receivables Analysis

HSCSW Stock

USD 0.04 0.00 0.00%

Heart Test financial indicator trend analysis is much more than just examining Heart Test Laboratories latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Heart Test Laboratories is a good investment. Please check the relationship between Heart Test Short Long Term Debt and its Net Receivables accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Short Long Term Debt vs Net Receivables

Short Long Term Debt vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Heart Test Laboratories Short Long Term Debt account and Net Receivables. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Heart Test's Short Long Term Debt and Net Receivables is 0.1. Overlapping area represents the amount of variation of Short Long Term Debt that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Heart Test Laboratories, assuming nothing else is changed. The correlation between historical values of Heart Test's Short Long Term Debt and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt of Heart Test Laboratories are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Short Long Term Debt i.e., Heart Test's Short Long Term Debt and Net Receivables go up and down completely randomly.

Correlation Coefficient

0.1

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Short Long Term Debt

The total of a company's short-term and long-term borrowings.

Net Receivables

Most indicators from Heart Test's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Heart Test Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

At this time, Heart Test's Issuance Of Capital Stock is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to climb to 0.23 in 2025, whereas Selling General Administrative is likely to drop slightly above 2.5 M in 2025.

	2022	2023	2024	2025 (projected)
Interest Expense	243.2K	354.1K	407.2K	242.9K
Depreciation And Amortization	26.9K	95.1K	109.4K	58.5K

Interest Expense Depreciation And Amortization

Heart Test fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt
Total Assets		-0.17	0.62	0.39	0.9	0.56	0.77	-0.85	-0.86	0.42	1.0	1.0	0.47	-0.09	1.0	0.99	-0.64	-0.21	0.68	-0.86	0.99	0.88	0.16	0.99	0.75	0.2
Short Long Term Debt Total	-0.17		0.61	0.77	-0.58	-0.7	0.33	0.64	-0.11	0.59	-0.13	-0.26	0.59	0.99	-0.13	-0.27	-0.5	0.99	-0.5	-0.28	-0.13	-0.13	0.92	-0.25	-0.48	0.86
Other Current Liab	0.62	0.61		0.89	0.23	0.06	0.94	-0.18	-0.83	0.88	0.65	0.54	0.92	0.63	0.65	0.56	-0.95	0.58	0.33	-0.92	0.67	0.66	0.79	0.54	0.37	0.76
Total Current Liabilities	0.39	0.77	0.89		-0.03	-0.24	0.76	0.1	-0.6	0.92	0.43	0.31	0.71	0.76	0.43	0.31	-0.73	0.73	0.0	-0.72	0.42	0.38	0.92	0.31	0.05	0.96
Total Stockholder Equity	0.9	-0.58	0.23	-0.03		0.76	0.48	-0.99	-0.66	0.06	0.88	0.94	0.13	-0.5	0.88	0.94	-0.31	-0.61	0.76	-0.58	0.88	0.79	-0.28	0.93	0.82	-0.22
Property Plant And Equipment Net	0.56	-0.7	0.06	-0.24	0.76		0.38	-0.83	-0.48	0.02	0.54	0.6	0.04	-0.7	0.54	0.64	-0.12	-0.71	0.96	-0.33	0.57	0.72	-0.54	0.58	0.95	-0.47
Current Deferred Revenue	0.77	0.33	0.94	0.76	0.48	0.38		-0.45	-0.91	0.8	0.79	0.71	0.84	0.36	0.79	0.73	-0.89	0.3	0.61	-0.95	0.81	0.87	0.54	0.7	0.65	0.56
Net Debt	-0.85	0.64	-0.18	0.1	-0.99	-0.83	-0.45		0.65	-0.02	-0.83	-0.89	-0.11	0.58	-0.83	-0.9	0.26	0.67	-0.82	0.52	-0.83	-0.78	0.37	-0.88	-0.86	0.3
Retained Earnings	-0.86	-0.11	-0.83	-0.6	-0.66	-0.48	-0.91	0.65		-0.69	-0.88	-0.82	-0.77	-0.14	-0.88	-0.85	0.85	-0.08	-0.68	0.94	-0.9	-0.84	-0.39	-0.82	-0.7	-0.39
Accounts Payable	0.42	0.59	0.88	0.92	0.06	0.02	0.8	-0.02	-0.69		0.46	0.35	0.72	0.55	0.46	0.37	-0.76	0.56	0.25	-0.76	0.47	0.46	0.79	0.32	0.27	0.82
Cash	1.0	-0.13	0.65	0.43	0.88	0.54	0.79	-0.83	-0.88	0.46		0.99	0.51	-0.05	1.0	0.99	-0.67	-0.17	0.67	-0.88	1.0	0.89	0.2	0.99	0.75	0.23
Non Current Assets Total	1.0	-0.26	0.54	0.31	0.94	0.6	0.71	-0.89	-0.82	0.35	0.99		0.39	-0.18	0.99	1.0	-0.57	-0.3	0.7	-0.81	0.98	0.87	0.07	1.0	0.77	0.12
Non Currrent Assets Other	0.47	0.59	0.92	0.71	0.13	0.04	0.84	-0.11	-0.77	0.72	0.51	0.39		0.62	0.51	0.43	-0.97	0.6	0.31	-0.82	0.55	0.56	0.69	0.4	0.31	0.57
Long Term Debt	-0.09	0.99	0.63	0.76	-0.5	-0.7	0.36	0.58	-0.14	0.55	-0.05	-0.18	0.62		-0.05	-0.19	-0.55	0.98	-0.49	-0.34	-0.06	-0.08	0.92	-0.16	-0.45	0.84
Cash And Short Term Investments	1.0	-0.13	0.65	0.43	0.88	0.54	0.79	-0.83	-0.88	0.46	1.0	0.99	0.51	-0.05		0.99	-0.67	-0.17	0.67	-0.88	1.0	0.89	0.2	0.99	0.75	0.23
Net Receivables	0.99	-0.27	0.56	0.31	0.94	0.64	0.73	-0.9	-0.85	0.37	0.99	1.0	0.43	-0.19	0.99		-0.6	-0.3	0.74	-0.83	0.99	0.89	0.07	0.99	0.81	0.1
Common Stock Shares Outstanding	-0.64	-0.5	-0.95	-0.73	-0.31	-0.12	-0.89	0.26	0.85	-0.76	-0.67	-0.57	-0.97	-0.55	-0.67	-0.6		-0.5	-0.38	0.93	-0.71	-0.66	-0.69	-0.58	-0.41	-0.58
Non Current Liabilities Total	-0.21	0.99	0.58	0.73	-0.61	-0.71	0.3	0.67	-0.08	0.56	-0.17	-0.3	0.6	0.98	-0.17	-0.3	-0.5		-0.5	-0.26	-0.17	-0.17	0.9	-0.29	-0.49	0.81
Capital Lease Obligations	0.68	-0.5	0.33	0.0	0.76	0.96	0.61	-0.82	-0.68	0.25	0.67	0.7	0.31	-0.49	0.67	0.74	-0.38	-0.5		-0.55	0.71	0.85	-0.31	0.67	0.99	-0.25
Inventory	-0.86	-0.28	-0.92	-0.72	-0.58	-0.33	-0.95	0.52	0.94	-0.76	-0.88	-0.81	-0.82	-0.34	-0.88	-0.83	0.93	-0.26	-0.55		-0.9	-0.83	-0.57	-0.81	-0.61	-0.54
Other Current Assets	0.99	-0.13	0.67	0.42	0.88	0.57	0.81	-0.83	-0.9	0.47	1.0	0.98	0.55	-0.06	1.0	0.99	-0.71	-0.17	0.71	-0.9		0.9	0.2	0.98	0.77	0.21
Other Stockholder Equity	0.88	-0.13	0.66	0.38	0.79	0.72	0.87	-0.78	-0.84	0.46	0.89	0.87	0.56	-0.08	0.89	0.89	-0.66	-0.17	0.85	-0.83	0.9		0.09	0.87	0.9	0.14
Total Liab	0.16	0.92	0.79	0.92	-0.28	-0.54	0.54	0.37	-0.39	0.79	0.2	0.07	0.69	0.92	0.2	0.07	-0.69	0.9	-0.31	-0.57	0.2	0.09		0.08	-0.26	0.95
Net Invested Capital	0.99	-0.25	0.54	0.31	0.93	0.58	0.7	-0.88	-0.82	0.32	0.99	1.0	0.4	-0.16	0.99	0.99	-0.58	-0.29	0.67	-0.81	0.98	0.87	0.08		0.75	0.12
Property Plant And Equipment Gross	0.75	-0.48	0.37	0.05	0.82	0.95	0.65	-0.86	-0.7	0.27	0.75	0.77	0.31	-0.45	0.75	0.81	-0.41	-0.49	0.99	-0.61	0.77	0.9	-0.26	0.75		-0.2
Short Long Term Debt	0.2	0.86	0.76	0.96	-0.22	-0.47	0.56	0.3	-0.39	0.82	0.23	0.12	0.57	0.84	0.23	0.1	-0.58	0.81	-0.25	-0.54	0.21	0.14	0.95	0.12	-0.2

Click cells to compare fundamentals

Heart Test Account Relationship Matchups

Heart Test fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.9M	2.1M	3.3M	9.5M	10.9M	11.5M
Short Long Term Debt Total	3.1M	6.2M	1.6M	1.0M	932.7K	886.1K
Other Current Liab	422.4K	1.1M	672.0K	701.3K	806.5K	627.4K
Total Current Liabilities	1.2M	3.5M	1.8M	1.8M	2.0M	2.1M
Total Stockholder Equity	(1.9M)	(6.1M)	230.6K	7.3M	8.4M	8.8M
Property Plant And Equipment Net	289.3K	158.6K	590.7K	560.0K	644.0K	443.6K
Net Debt	2.4M	5.2M	(94.6K)	(4.8M)	(4.3M)	(4.1M)
Retained Earnings	(49.6M)	(54.4M)	(60.8M)	(67.4M)	(60.6M)	(63.7M)
Accounts Payable	335.8K	694.7K	631.4K	448.2K	515.4K	543.2K
Cash	723.5K	918.3K	1.7M	5.8M	6.7M	7.0M
Non Current Assets Total	289.3K	158.6K	590.7K	2.1M	2.5M	2.6M
Cash And Short Term Investments	723.5K	918.3K	1.7M	5.8M	6.7M	7.0M
Net Receivables	94.8K	2.3K	319.4K	876.7K	1.0M	1.1M
Common Stock Shares Outstanding	33.1K	33.2K	79.5K	352.5K	317.3K	301.4K
Liabilities And Stockholders Equity	1.9M	2.1M	3.3M	9.5M	10.9M	11.5M
Non Current Liabilities Total	2.6M	4.7M	1.2M	434.0K	390.6K	371.1K
Capital Lease Obligations	198.6K	91.0K	565.9K	536.3K	616.8K	370.4K
Inventory	750.8K	674.1K	676.4K	629.2K	566.3K	574.0K
Other Current Assets	163.8K	89.8K	359.8K	917.1K	1.1M	1.1M
Other Stockholder Equity	47.7M	48.3M	61.0M	74.7M	85.9M	61.4M
Total Liab	3.8M	8.1M	3.1M	2.2M	2.5M	4.2M
Net Invested Capital	970.1K	15.5K	1.2M	7.8M	9.0M	9.4M
Property Plant And Equipment Gross	707.7K	603.5K	1.1M	1.1M	1.2M	932.4K
Total Current Assets	1.6M	1.9M	2.7M	7.4M	8.5M	8.9M
Capital Stock	3.8K	3.8K	10.5K	1.1K	1.2K	1.2K
Net Working Capital	392.0K	(1.5M)	863.7K	5.6M	6.4M	6.8M
Short Term Debt	487.8K	1.7M	529.5K	602.3K	692.6K	832.6K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Heart Short Long Term Debt vs Net Receivables Analysis

Short Long Term Debt vs Net Receivables

Short Long Term Debt vs Net Receivables Correlation Analysis

Correlation Coefficient

Short Long Term Debt

Net Receivables

Heart Test fundamental ratios Correlations

Heart Test Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Heart Test fundamental ratios Accounts

Also Currently Popular

Additional Tools for Heart Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Other Current Assets	+ 1.0	Cash
Net Receivables	+ 1.0	Non Current Assets Total

Net Debt	- 0.99	Total Stockholder Equity
Common Stock Shares Outstanding	- 0.97	Non Currrent Assets Other
Inventory	- 0.95	Current Deferred Revenue
Common Stock Shares Outstanding	- 0.95	Other Current Liab
Inventory	- 0.92	Other Current Liab
Retained Earnings	- 0.91	Current Deferred Revenue